Diabetes is a widespread, growing epidemic

• According to the American Diabetes Association (ADA) 24 million people in the U.S. suffer from diabetes (Over 230 million worldwide).  Approximately 25% of Americans with diabetes are unaware they have the disease.  Over 1.5 million people are newly diagnosed with diabetes each year.
• The ADA reports that over 57 million people in the U.S. have pre-diabetes (impaired glucose tolerance and/or impaired fasting glycemia), a proven pre-cursor to the development of diabetes. 
• Diabetes is the 6th most common cause of death and the leading cause of blindness, kidney failure and non-traumatic amputation.
• The CDC reports a 50% increase in diabetes from 1997-2004.  This correlates with a 41% increase in diabetes-related physician visits.

The cost of diabetes is enormous and growing

• The annual cost of diabetes in the U.S. is $130 - 160 billion, including $58 billion due to lost worker productivity
• Diabetes comprises 25% of Medicare costs and 15% of all healthcare costs
• Diabetic individuals, on average, incur nearly 5 times the annual healthcare costs than people without the disease.

The market potential for Grove Instruments™ is significant

• The diabetes drug market was over $15 billion in 2006. The U.S. glucose monitoring market will reach $3.5 billion in 2008 ($8 billion worldwide), expanding 7.2% annually from 2003-2008.